Biz in Saigon

Ho Chi Minh City Establishes Venture Capital Fund to Fuel Innovation and Startups

The Ho Chi Minh City (HCMC) People’s Committee has officially approved a proposal to establish the HCMC Venture Capital Fund (HVCF). The fund is designed to provide additional financial resources for innovative startups, foster scientific and technological development, [...]

Read more

Latest News

Moonbird Claims Evaluated: Guided Breathing Therapy Device for Meditation-Like Calming Benefits for Relaxation & Sleep Support

A 2026 informational overview of Moonbird’s tactile breathing coach technology, EEG brain scan research references, [...]

Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定,并通过 IND 审评

FDA 授予 Daretabart (hu1418K322A) 快速通道认定资格,以解决高危神经母细胞瘤领域存在的重大未满足医疗需求,允许该药物进入加速评审和滚动审评流程 FDA 通过新药临床研究 (IND) 申请后,即可在高危神经母细胞瘤复发及难治性患者中启动 SHINE II/III 期临床试验 Daretabart (hu1418K322A) 第一个商业化规模 [...]

Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee

Company Marks First Annual Meeting at Historic Perkins Place Office Building as It Prepares to [...]

Enara Bio Presents First-in-Class DARKFOX-Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential in Solid Tumor Immunotherapy

First‑in‑class DARKFOX‑targeting bispecific T cell engager: ENA101 is designed to selectively recognize the DARKFOX‑A3 peptide [...]

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026

SHANGHAI, April 20, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: [...]

Most Read

Don’t miss it

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering [...]

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

Collaboration Expected to Advance FS2 Topical Platform and Strengthen BGLC’s Biotech Footprint in Asia KUALA [...]

OXB honoured at 2025 CDMO Leadership Awards in ‘Cell & Gene Therapy – Global’ category

OXB honoured at 2025 CDMO Leadership Awards in ‘Cell & Gene Therapy – Global’ category [...]

Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment

New program delivers TULSA Procedure’s precision treatment – minimal side effects, no overnight hospital stay [...]

Doze Luxury Bedding Launches Crowdfunding Campaign on StartEngine to Expand Product Line and Continue Growth

Luxury Bedding Brand Invites Supporters and Investors to Join its Journey BOCA RATON, Fla., Jan. [...]

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

AUSTIN, Aug. 19, 2025 (GLOBE NEWSWIRE) — Rein Therapeutics (“Rein”) (NASDAQ: RNTX), a biopharmaceutical company advancing [...]